ESR1/2 might directly or indirectly regulate oncogenic pathways in non-small-cell lung cancer, and FOXO1 expression is a favourable prognostic factor in non-small-cell lung cancer30,31. The gene discussed is ESR1; the disease is non-small cell lung carcinoma.